334 related articles for article (PubMed ID: 19162117)
1. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.
Jacobsson S; Hedberg ST; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
Vaccine; 2009 Mar; 27(10):1579-84. PubMed ID: 19162117
[TBL] [Abstract][Full Text] [Related]
2. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.
Jacobsson S; Thulin S; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
Vaccine; 2006 Mar; 24(12):2161-8. PubMed ID: 16321460
[TBL] [Abstract][Full Text] [Related]
3. Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.
Hadad R; Jacobsson S; Pizza M; Rappuoli R; Fredlund H; Olcén P; Unemo M
APMIS; 2012 Sep; 120(9):750-60. PubMed ID: 22882265
[TBL] [Abstract][Full Text] [Related]
4. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.
Bambini S; Muzzi A; Olcen P; Rappuoli R; Pizza M; Comanducci M
Vaccine; 2009 May; 27(21):2794-803. PubMed ID: 19428890
[TBL] [Abstract][Full Text] [Related]
5. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
[TBL] [Abstract][Full Text] [Related]
6. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
7. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
8. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
Bai X; Borrow R
Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
[TBL] [Abstract][Full Text] [Related]
9. Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection.
Seib KL; Oriente F; Adu-Bobie J; Montanari P; Ferlicca F; Giuliani MM; Rappuoli R; Pizza M; Delany I
Vaccine; 2010 Mar; 28(12):2416-27. PubMed ID: 20067752
[TBL] [Abstract][Full Text] [Related]
10. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.
Jiang HQ; Hoiseth SK; Harris SL; McNeil LK; Zhu D; Tan C; Scott AA; Alexander K; Mason K; Miller L; DaSilva I; Mack M; Zhao XJ; Pride MW; Andrew L; Murphy E; Hagen M; French R; Arora A; Jones TR; Jansen KU; Zlotnick GW; Anderson AS
Vaccine; 2010 Aug; 28(37):6086-93. PubMed ID: 20619376
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
Rossi R; Beernink PT; Giuntini S; Granoff DM
Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in vaccines to prevent meningococcal serogroup B infections.
Vermont CL; van den Dobbelsteen GP; de Groot R
Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal serogroup B infections: a search for a broadly protective vaccine.
Vermont CL; van den Dobbelsteen GP
Expert Rev Vaccines; 2003 Oct; 2(5):673-81. PubMed ID: 14711328
[TBL] [Abstract][Full Text] [Related]
14. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
[TBL] [Abstract][Full Text] [Related]
15. Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine.
Claus H; Jördens MS; Kriz P; Musilek M; Jarva H; Pawlik MC; Meri S; Vogel U
Vaccine; 2012 Jan; 30(2):155-60. PubMed ID: 22107847
[TBL] [Abstract][Full Text] [Related]
16. Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis.
Kelly A; Jacobsson S; Hussain S; Olcén P; Mölling P
APMIS; 2013 Jan; 121(1):56-63. PubMed ID: 23030708
[TBL] [Abstract][Full Text] [Related]
17. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
18. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.
Mothibeli KM; du Plessis M; von Gottberg A; Murphy E; Hoiseth SK; Zlotnick G; Klugman KP
Vaccine; 2011 Mar; 29(11):2187-92. PubMed ID: 21144918
[TBL] [Abstract][Full Text] [Related]
19. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.
Holst J; Comanducci M; Bambini S; Muzzi A; Comandi S; Oksnes J; DeTora L; Pizza M; Rappuoli R; Caugant DA
Vaccine; 2014 May; 32(23):2722-31. PubMed ID: 24631075
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation.
Brehony C; Rodrigues CMC; Borrow R; Smith A; Cunney R; Moxon ER; Maiden MCJ
Vaccine; 2016 Sep; 34(39):4690-4697. PubMed ID: 27521232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
